dc.description.abstract | Background
Chronic and Long-term use of khat may cause neuro-cognitive changes, which have been
elucidated in behavioural studies. These may correlate with structural changes in the
cytoarchitecture and histomorphometry of neuronal cells. With current research showing the
centrality of astrocytes and other glial cells in neuronal signalling, there is possibility that these
cells are also affected by chronic khat use. There’s little literature on the structural changes in the
prefrontal cortex neuronal and astrocytic cytoarchitecture and morphometry in chronic khat
users.
Objective
To describe the changes in neuronal architecture and density, as well as astrocyte morphology in
rats after long-term use of khat (miraa).
Study design
Randomized experimental study design.
Materials and Methods
Young adult male Wistar rats, aged 2-3 months, weighing 200-300 grams were used in this
study. They were randomized into four groups of 11 each (control, K500, K1000 and K2000) to
correspond with those used as controls, those that received 500mg/kg, 1000mg/kg and
2000mg/kg body weight khat extracts respectively. We purchased fresh khat leaves from
Mikinduri market in Meru and prepare crude extract using a validated method.
The control rats were fed on normal diet, while experimental groups were fed on normal diet
and khat extracts using oral gavage for 6 weeks. The animals were sacrificed and their brains
removed. They were processed with Haematoxylin and Eosin and Toluidine blue for general
histology. We performed immunohistochemical visualization of individual neurocellular
populations across the four animal groups as follows: Glial Acidic Fibrillary Protein for
astrocytes, 2’, 3’ cyclic nucleotide phosphodiesterase for oligodendrocytes and doublecortin for
immature neurons.
Data Analysis
Photomicrographs of the stained sections were transferred to Image J-Fiji software to study
normal and apoptotic pyramidal neuronal cell density, astrocyte density, oligodendrocyte density
and the density of immature neurons. Data was entered into SPPS, IBM version 28.0 for
analysis. We used Kruskal-Wallis H test to correlate the four animal groups in terms of neuronal
densities and astrocyte densities.
Results
The mean body weight, average brain weight and maximum cortical length of the rat brains
demonstrated a significant decrease with increasing khat doses compared to controls. We
observed a significant increase in the density of apoptotic pyramidal neurons in experimental
groups compared to controls (p=0.027), while a decrease in normal pyramidal neurons was noted
with increasing doses of khat. Further, we observed a non-significant increase in immature
doublecortin staining neurons in khat-fed rats compared to controls.
There was observed a significant increase in immunoreactive astrocytes with high khat doses
(2000mg/kg), coupled with increase complexity of astrocytic processes and gliosis. No group
differences were noted in immunoreactive oligodendrocyte density with khat use although there
was discernible reduction in myelination with increasing doses of khat.
Conclusions
This study has demonstrated a reduction in gross cortical indices, an increase in pyramidal
neuronal apoptosis, a reduction in pyramidal neuronal density with increasing khat doses. This
underscores the potential neurotoxic effects of high khat doses. The increase in astrocyte
complexity, reduction in myelination and increase in immature neuroblasts in high khat doses
compared to controls adds insights into the potential mechanisms involved in khat-induced brain
changes, as well as the role of adult neurogenesis in substance use.
Recommendations
We recommend that a longitudinal study should be designed to identify the histological and
immunohistochemical changes in the prefrontal cortex along the continuum of khat use so as to
identify the time when changes start occurring. To eludicate the process of neuronal loss, ki-67
and caspase staining should be performed. | en_US |
dc.description.department | a
Department of Psychiatry, University of Nairobi, ; bDepartment of Mental Health, School of Medicine,
Moi University, Eldoret, Kenya | |